卖什么
AI-powered care for seniors with chronic disease
商业模式拆解
买家：谁掌握预算？
未核实Health plan population health / medical management teams (Medicare Advantage); also referring physicians.
触发点：什么让他们现在购买？
COPD is costly in MA plans (high-risk COPD members cost $29,564 PMPY, 2.9x non-COPD members) and in-person pulmonary rehab has access barriers.
工作流：什么输入变成什么输出？
Physician or plan refers patient; 1:1 assessment with respiratory therapist; 9 weeks, 2 live small-group sessions per week (91 minutes) with aerobic/anaerobic exercise, breathing techniques and medication management; then ongoing monitoring.
经济账：省了什么，怎么收费？
Sold to health plans on cost-savings ROI: claims 3.1x ROI, predicted $8,245 PMPY savings, about $9.8M per 100,000 MA members, mainly from reduced inpatient and SNF costs.
渠道：怎么接触到客户？
Demo/contact-sales to health plans and population-health buyers, plus physician referral and patient self-referral forms.
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| — | YC 2023 冬季 | — | Y Combinator | ycombinator.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-12.